By Aaron Bloom

DocMJ is Florida’s largest and most experienced group of certified medical marijuana physicians. We have been providing appropriate medical marijuana recommendations to qualified patients since 2016. We are proud to offer our patients world-class care at an affordable price. All our physicians and mental health counselors are experienced experts who really understand the needs of patients who seek medical cannabis as an alternative to prescription drugs.

One of the things that sets DocMJ apart from other providers is that we work hard to understand the complete patient. We recognized early on that patients who suffer from some chronic anxiety conditions (e.g. PTSD), may need more than just medicinal relief. We know that research has shown that when you combine medical marijuana use with counseling, you not only treat the symptoms but also the underlying cause. For us, this is just a part of helping all patients have their own individual wellness journey with medical cannabis.

We have educational resources that are easily accessible via our website at www.docmj.com. Additionally, patients can feel connected by watching any of our numerous videos including patient testimonials, cannabis educational videos and blogs, and more. When it comes to medical cannabis, qualifying conditions, and positive treatment outcomes, DocMJ is a patient’s best alternative for their treatment journey. We have everything a patient needs under one amazing umbrella website that is easy to navigate and helps patients feel comfortable with medical cannabis.

Patients don’t have to suffer from chronic pain, anxiety, PTSD and a host of other qualified conditions in Florida. They can rely on DocMJ to help them learn everything they need to know about medical marijuana and most importantly, get the real relief they have been searching for.

Aaron Bloom is CEO at DocMJ. To learn more, visit www.docmj.com.



Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Boca Raton, FL.

“Trulieve is excited to expand access to medical cannabis in the Boca Raton market and build strong relationships in the community,” said Kim Rivers, CEO of Trulieve. “Our company is driven by our commitment to providing tailored, high-quality patient care in a safe and comfortable environment.”

As the state’s leading medical cannabis provider, Trulieve’s retail employees are trained to provide personalized patient care and support individuals at every stage of their cannabis journey. Trulieve dispensaries throughout Florida offer on-site consultations to help patients obtain appropriate medical products and dosages to ensure optimal cannabis experiences.



One of the largest cannabis companies in the world by market cap is seeking out its first medical cannabis retail facility in Florida.

Las Vegas-based Planet 13 Holdings, a vertically integrated multistate operator, announced its plans to set up a medical dispensary in the town of Orange Park, a suburb on Jacksonville’s south side.

The planned location is on a busy retail corridor next to a Walmart Superstore and near the scenic St. John’s River, a popular destination for tourists and local residents, according to the company.

“We’ve been heads down working hard on our Florida expansion,” Planet 13 co-CEO Bob Groesbeck said in a press release. “We are progressing well on locating and working on both cultivation and retail under a dual track plan to bring both online at the same time. This is the first signed lease of our initial six planned neighborhood style stores all focused on major population centers and heavily trafficked retail locations.”

The move will expand upon Planet 13’s Nevada footprint, which includes its Las Vegas dispensary that became the largest in the world at 112,000 square feet when it opened in 2018, and it’s 55,000-square-foot retail facility in Orange County, Calif. The company has multiple “superstores” in each state as well as cultivation, production and distribution licenses.

The pathway to its Florida expansion opened when Planet 13 entered into an agreement with a subsidiary of Harvest Health & Recreation Inc. in September to acquire a license for $55 million to operate as a Medical Marijuana Treatment Center (MMTC) in the state. Regulated by the Florida Department of Health, MMTCs are the only businesses authorized to dispense medical cannabis to qualified patients and caregivers in the state.



Cresco Labs Inc. announced the grand opening of a new Sunnyside dispensary in Lady Lake, Florida. The new store marks a milestone in Cresco’s nationwide retail expansion, bringing the Company’s total retail footprint to 50 locations across seven states and 16 total stores in the state of Florida.

“Our 50th store in Florida marks the achievement of a key goal established in 2021 to expand company-owned retail locations in the state, aiming for 16 dispensaries open by the anniversary of the Bluma acquisition,” said Charlie Bachtell, CEO & Co-founder at Cresco Labs. “Over the past year, we’ve done a good job leveraging our extraordinarily productive Sunnyside banner to grow retail revenue, expanding the ways Cresco’s brands reach and interact with consumers. Today’s opening is an exciting moment in Cresco’s history—it’s truly incredible to see both how far this organization has come and the outstanding execution from our retail team.”



Cresco Labs announced the launch of its High Supply, Good News, and Remedi brands in Florida. In addition, the Company released a new edibles brand, Sunnyside Chews, available only in the state. Cresco Labs will soon expand to Florida its premium craft-quality flower brand, FloraCal Farms, and bestselling flagship brand, Cresco.

“We’ve demonstrated our ability to reach leading market share positions in large medical markets based on the strength of our products and the value we provide patients. We’re proud to offer those popular brands to Florida patients for the first time,” said Charlie Bachtell, CEO & Co-founder at Cresco Labs. “We’re relentlessly focused on quality, consistency and availability, and we’ll keep that promise to patients as we continue to scale in the state.”